Company & Sponsor Intelligence

Dart NeuroScience, LLC

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials3

Recruiting0

Completed0

Countries1

Therapeutic footprint

other_neurologyparkinsonsstroke

Indexed studies

NCT03306329DNS-7801 vs. Placebo in Parkinson's Disease
parkinsons · United StatesPHASE2

NCT01215552Study of the Inhibition of [11C]R-rolipram Binding to Brain Phosphodiesterase - 4 (PDE-4) by HT-0712
other_neurology · United StatesPHASE1

NCT02530307HT-3951 vs. Placebo in Stroke Rehabilitation
stroke · United StatesPHASE2

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →